Related Experiment Video
Updated: May 8, 2026

In Vivo Proximity Biotinylation for Protein Interaction Studies in Paramecium tetraurelia
Published on: September 12, 2025
Biotinidase deficiency in childhood
Viswanathan Venkataraman1, Padma Balaji, Debasis Panigrahi
1Department of Pediatric Neurology, Kanchi Kamakoti Childs Trust Hospital, Nungambakkam, Chennai, Tamil Nadu, India.
Insights
Biotinidase deficiency, a treatable metabolic disorder, can cause seizures and neurological symptoms in infants. Early diagnosis and biotin treatment lead to dramatic seizure control and prevent severe complications.
Area of Science:
- Metabolic disorders
- Biochemistry
- Clinical genetics
Background:
- Biotinidase deficiency is an inherited metabolic disorder affecting biotin metabolism.
- Early diagnosis and treatment are crucial to prevent neurological sequelae.
Observation:
- Seven patients with biotinidase deficiency were studied.
- Presentation varied from birth to 5 months, with seizures being the most common symptom.
- Cutaneous manifestations like sparse hair were present in some, but not all patients.
Findings:
- Serum biotinidase activity was measured using spectrophotometric analysis.
- All patients showed a dramatic clinical response to biotin supplementation, with complete seizure control.
- No patients developed acidosis or hyperammonemia; however, one patient had a residual neurological deficit.
Implications:
- Biotinidase deficiency should be considered in infants with neurological symptoms, particularly seizures, even without typical skin or laboratory findings.
- Prompt biotin treatment is effective in managing seizures and preventing severe outcomes like optic atrophy and hearing loss.
- This highlights the importance of newborn screening and timely intervention for metabolic disorders.
Abstract:
This study reports the clinical, laboratory profile and outcome in seven patients with biotinidase deficiency. The serum biotinidase activity was assayed using spectrophotometric analysis. The age at presentation varied from day 1 of life to the 5 th month. Seizures were the presenting complaint in six patients and clonic seizures were the predominant seizure type. Sparse hair was seen in four patients, while three did not have any cutaneous manifestation. None of the patients had acidosis or hyperammonemia. The clinical response to biotin was dramatic with seizure control in all patients. One patient had neurological deficit at follow-up, while none had optic atrophy or sensorineural hearing loss. Biotinidase deficiency, a potentially treatable condition, should be thought of in any child presenting with neurological symptoms, especially seizures, even in the absence of cutaneous or laboratory manifestations.
Related Concept Videos
Pedigree Analysis
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Probability Laws
Vitamins
Sulfur Assimilation

